By Cleaving GABA(A) Receptors, BACE1 Lifts Lid on Hyperactivity
In a mouse model of amyloidosis, the BACE1 enzyme snipped subunits of the GABA(A) receptor, squelching its inhibitory function.
In a mouse model of amyloidosis, the BACE1 enzyme snipped subunits of the GABA(A) receptor, squelching its inhibitory function.
Thinning out glycoproteins in the brain blood vessels of young mice allowed blood to leak into the brain. Promoting glycosylation in old mice strengthened the barrier.
In neurons, FAM171A2 opens the door to toxic fibrils. An approved cancer drug slams it shut.
The man has lots of plaques but few tangles 18 years after his expected age of onset; potential protective factors include extensive heat shock protein expression.
In neurons from a person with HD, knocking down MSH3 kept CAG nucleotide expansions from growing even longer.
The marker detected plaques and tangles with 90 percent accuracy in almost 200 autopsy-confirmed frontotemporal dementia cases.
Plasma Aβ42/40 ratios drop in people soon after COVID-19 infection even for mild cases. Does this mean they are at higher risk for dementia?
Amyloid and tau accumulation patterns differ in black, white, and Hispanic people.
It appears that bristly, bottlebrush-shaped glycoproteins on the interior of brain blood vessels control their permeability. These glycoproteins dwindle with age. Restoring them in old mice firmed up the barrier, while removing them in young mice caused vessels to leak blood. The glycoproteins wane in Alzheimer’s and Huntington’s diseases.
Boasting resilience to amyloid, Doug Whitney, a DIAN participant with the Volga PS2 mutation, has many plaques but few tangles, and he remains cognitively healthy 18 years past the age when Alzheimer's symptoms were estimated to start. Multiomic analyses suggest protective variants in CD33, tau, and other genes, but also an intriguing abundance of heat shock proteins and of metabolic factors implicated in aging research.
New in last 7 days
Latest Comments